- Joined
- Jun 19, 2013
- Messages
- 6,845
GLP-1–based peptides like Ozempic, Mounjaro, and now newer agents such as Retatrutide have become a multi-billion-dollar market and are rapidly spreading into the fitness world as well. One of the most common questions I get is:
“If I’m using Ozempic / Mounjaro (or even Retatrutide), does it make sense to combine them with steroids or HGH to preserve muscle?”
I put together a full write-up on exactly that:
Should Mounjaro, Ozempic, or Retatrutide Be Combined with Steroids and HGH?
Drugs like Ozempic/Wegovy (semaglutide), Mounjaro/Zepbound (tirzepatide) and the newer triple agonist Retatrutide are absolute monsters for weight loss. They crush appetite, calories plummet, the scale moves fast… but the drop is not only fat. A noticeable chunk of that loss is lean body mass—especially if:
That’s the problem people are trying to “fix” with steroids or HGH.
Even with normal dieting, it’s pretty typical for 25–35% of total weight loss to come from muscle, not just fat.
Now add in GLP-1 / GIP / triple-agonist drugs:
Result: awesome fat loss, but a higher risk of sarcopenia (muscle loss), especially in older lifters and TRT users who already sit closer to the edge hormonally.
From a pure physiology standpoint:
So on the body-comp level they actually counterbalance GLP-1 drugs:
That’s why, in the real world, plenty of coaches and athletes quietly pair mild cycles with GLP-1s.
But that doesn’t make it “safe”:
So yes, the combo can deliver impressive recomposition—but the health cost depends a lot on age, baseline risk and dose choices.
What HGH tends to do:
Meanwhile GLP-1 / GIP drugs:
So metabolically it’s a big yin–yang pairing:
On paper that’s an incredible recomposition stack. In reality, we have:
So it’s powerful, but it’s also pretty experimental.
Retatrutide takes things even further. It’s an experimental triple-agonist peptide (GLP-1, GIP, and glucagon receptors), designed to hit several metabolic pathways at once:
Early phase-2 data show very large weight-loss percentages (~22–24%+ in some protocols). Most of that loss is fat mass, but lean mass still takes a hit, similar to (or even more pronounced than) other powerful incretin drugs.
Right now:
Because of the lack of long-term safety data, any attempt to combine Retatrutide with steroids or HGH is essentially experimental. Many advanced users are already playing with these stacks in the wild with quite promising results
In the article I also focus on the stuff that actually has evidence behind it and doesn’t wreck your health:
Those basic pieces already go a long way toward keeping muscle while you use GLP-1 drugs for fat loss.
If you’re on (or thinking about) Ozempic, Mounjaro or Retatrutide and want to understand how they really interact with muscle mass, steroids and HGH, you can dive into the full breakdown here:
Should Mounjaro, Ozempic, or Retatrutide Be Combined with Steroids and HGH?
“If I’m using Ozempic / Mounjaro (or even Retatrutide), does it make sense to combine them with steroids or HGH to preserve muscle?”
I put together a full write-up on exactly that:
Should Mounjaro, Ozempic, or Retatrutide Be Combined with Steroids and HGH?Big picture in one paragraph
Drugs like Ozempic/Wegovy (semaglutide), Mounjaro/Zepbound (tirzepatide) and the newer triple agonist Retatrutide are absolute monsters for weight loss. They crush appetite, calories plummet, the scale moves fast… but the drop is not only fat. A noticeable chunk of that loss is lean body mass—especially if:
- you’re eating far less food overall
- daily protein quietly falls
- training intensity and volume take a hit
That’s the problem people are trying to “fix” with steroids or HGH.
Why GLP-1 drugs can eat into your muscle
Even with normal dieting, it’s pretty typical for 25–35% of total weight loss to come from muscle, not just fat.
Now add in GLP-1 / GIP / triple-agonist drugs:
- appetite gets annihilated
- calorie intake craters
- recovery and training sometimes suffer
Result: awesome fat loss, but a higher risk of sarcopenia (muscle loss), especially in older lifters and TRT users who already sit closer to the edge hormonally.
Using steroids on top of Ozempic / Mounjaro / Retatrutide
From a pure physiology standpoint:
- Anabolic steroids are about the strongest tools we have against muscle wasting in a deficit.
- They ramp up protein synthesis, improve nitrogen balance and help maintain or even increase lean mass.
So on the body-comp level they actually counterbalance GLP-1 drugs:
- GLP-1s → less food, less weight, more risk to muscle
- Anabolics → more muscle / better preservation despite low calories
That’s why, in the real world, plenty of coaches and athletes quietly pair mild cycles with GLP-1s.
But that doesn’t make it “safe”:
- higher hematocrit, blood pressure and CV strain
- worse lipid profile, liver stress (especially with orals)
- HPTA shutdown, fertility issues, mood and sleep changes
So yes, the combo can deliver impressive recomposition—but the health cost depends a lot on age, baseline risk and dose choices.
HGH together with GLP-1 / GIP / triple agonists
What HGH tends to do:
- strongly increases lipolysis, especially visceral fat
- helps maintain or raise lean mass
- pushes blood glucose up
- makes insulin sensitivity worse
Meanwhile GLP-1 / GIP drugs:
- improve insulin sensitivity
- lower fasting and post-meal glucose
- reduce appetite and spontaneous calorie intake
So metabolically it’s a big yin–yang pairing:
- HGH → more fat burning, but rougher on glucose control
- GLP-1s → better glycemic control, cleaner insulin profile, less hunger
On paper that’s an incredible recomposition stack. In reality, we have:
- almost no long-term safety data on running both at non-replacement doses
- overlapping sides (GI issues from GLP-1s, edema / CTS / joint pain from HGH, etc.)
So it’s powerful, but it’s also pretty experimental.
Retatrutide: the triple-agonist wild card
Retatrutide takes things even further. It’s an experimental triple-agonist peptide (GLP-1, GIP, and glucagon receptors), designed to hit several metabolic pathways at once:
- GLP-1 → appetite, glucose control
- GIP → insulin response, energy balance
- Glucagon → energy expenditure and fat oxidation
Early phase-2 data show very large weight-loss percentages (~22–24%+ in some protocols). Most of that loss is fat mass, but lean mass still takes a hit, similar to (or even more pronounced than) other powerful incretin drugs.
Right now:
- It is not yet FDA-approved and still under clinical investigation.
- Despite that, it’s already becoming popular in some circles due to its dramatic results.
Because of the lack of long-term safety data, any attempt to combine Retatrutide with steroids or HGH is essentially experimental. Many advanced users are already playing with these stacks in the wild with quite promising results
What isn’t experimental: protecting muscle the boring way
In the article I also focus on the stuff that actually has evidence behind it and doesn’t wreck your health:
- Heavy resistance training 3–5x/week
- Protein in the ~1.6–2.2 g/kg bodyweight range, every day
- A sensible calorie deficit instead of crash dieting
- Considering TRT / GH replacement only if there’s a documented deficiency, and doing it under a physician who knows hormones
Those basic pieces already go a long way toward keeping muscle while you use GLP-1 drugs for fat loss.
If you’re on (or thinking about) Ozempic, Mounjaro or Retatrutide and want to understand how they really interact with muscle mass, steroids and HGH, you can dive into the full breakdown here:
Should Mounjaro, Ozempic, or Retatrutide Be Combined with Steroids and HGH?
Explore useful guidance and comparisons:
Authentic pharmacy-grade products
